StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Rare Disease (Alexion) — Europe YoY CER by Quarter

Rare Disease (Alexion) — Europe YoY CER (%) (%)

QuarterlyAnnual

AstraZeneca Rare Disease (Alexion) — Europe YoY CER: 3.0% in Q2 2026, up 2.0 pts from a year earlier.

Latest, Q2 2026
3.0%
Period ended Jun 30, 2026
Change on a year earlier
+2.0 pts
1.0% in Q2 2025
History
20 quarters
Since Q3 2021
Sources
20
Documents cited below

Where the Q2 2026 figure comes from

“|| Rare Disease | | 2,490 | | 9 | | 8 | | 1,452 | | 8 | | 305 | | 10 | | 6 | | 442 | | 7 | | 3 | | 291 | | 13 | | 20”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Therapy Area Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRare Disease (Alexion) — Europe YoY CER (%) (%)Year on yearSource
Q2 2026Jun 30, 20263.0%+2.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20266.0%+13.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20254.0%+2.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-2.0%-2.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20251.0%-2.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-7.0%-8.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20242.0%+5.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20240.0%-8.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20243.0%+1.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20241.0%-13.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-3.0%-10.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20238.0%+2.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20232.0%-13.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202314.0%+6.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20227.0%+2.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20226.0%-6.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Rare Disease (Alexion) — Europe YoY CER (%), quarterly Q3 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta-rare-eu-cer-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.